$OKLO

Sam Altman-backed OKLO Stock Drops As Q1 Loss Widens

Oklo (OKLO) shares fell about 3% after hours after the company reported a wider Q1 net loss of $33.1 million, or $0.19 per share, versus $9.8 million, or $0.07 a year earlier. Oklo also said it entered a strategic partnership with Battelle Energy Alliance for AI work tied to Idaho National Laboratory, and is moving into an NRC pre-application phase. JPMorgan set a neutral rating and $83 target; Tigress set Buy and $130.

Original reporting
Published Aug 13, 2026, 7:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OKLO
Bearish
medium confidence
Mentioned
$OKLO
Relevance
7/10
alphai data visualization · based on stocktwits.com
Decision brief

The 30-second read

$OKLOBearishMed
01

Why it matters

The widened Q1 loss is a direct negative fundamental datapoint, while the NRC pre-application transition and Battelle AI partnership are incremental positives for execution and design acceleration. Net effect is likely volatility with downside pressure until revenue/profit milestones become clearer.

02

Market read

Traders can reassess near-term risk after-hours on loss deterioration, while monitoring whether NRC progress and AI-enabled design work translate into measurable commercialization steps.

03

What to watch

The article cites an analyst consensus loss expectation and provides partnership framing, but it lacks cash balance, guidance, and concrete commercialization timelines that would clarify risk.

Relevance 7/10Novelty 6/10Timing: after-hours reaction to Q1 loss widening and same-day partnership/regulatory updates

Background

Oklo is a nuclear startup backed by Sam Altman, developing the Aurora small modular reactor and transitioning through NRC engagement toward deployment.

Company-level read

Ticker impact

$OKLOBearishMedium confidence
Context

Oklo shares fell after-hours as Q1 net loss widened to $33.1M and it disclosed a Battelle Energy Alliance AI partnership plus an NRC pre-application transition.

Expected impact

Bearish bias for the next session due to loss deterioration, partially offset by the NRC pre-application milestone and Battelle AI partnership.

Evidence & confidence

The article provides a concrete earnings datapoint (loss widened vs year-ago) and new operational/regulatory disclosures (NRC pre-application transition, AI partnership), which can move sentiment even without revenue.

Market effects

Reinforces investor focus on advanced nuclear/SMR commercialization pathways and NRC engagement as key catalysts.

Limited direct regional impact; Idaho National Laboratory involvement is US-based but not a broad macro driver.

Modest, as advanced nuclear demand tied to data centers is a global theme but the news is company-specific.

Counterpoint

The stock’s large recent run-up (nearly +50% in a month) suggests expectations are already high; the widened loss could be viewed as expected burn rather than a fundamental deterioration.

Key entities

  • Oklo

    Nuclear startup developing the Aurora SMR; reported Q1 loss widening and disclosed NRC pre-application transition plus a Battelle AI partnership.

  • Battelle Energy Alliance (BEA)

    Management and operating contractor for Idaho National Laboratory, partnering with Oklo on AI-enabled reactor and fuel-system design workflows.

  • Nuclear Regulatory Commission (NRC)

    Regulatory body whose pre-application phase milestone is described as a critical hurdle for Oklo’s deployment path.

  • Idaho National Laboratory (INL)

    National lab whose contractor (BEA) will support AI-enabled conceptual design work for Oklo under the partnership.

Related articles

$OKLOMed

Is Oklo a Millionaire Maker, or Is the Hype Overdone?

Oklo reported its first quarterly revenue for the quarter ended Aug. 7, generating $1.21 million versus none a year earlier, alongside a wider-than-expected net loss of about $48.5 million and operating expenses of about $74 million. The company said it has $3 billion in total liquidity and that its Groves Reactor reached first criticality. Oklo shares were up about 14% on the news.

$OKLOMed

Oklo Stock’s 14% Rally Leaves Investors Paying $6 Billion for Execution

Oklo Inc. (OKLO) shares rose 14.8% on Friday and 24.7% last week, though the stock is still down 32.5% in 2026. Q2 revenue was $1.2 million, mainly from acquired businesses, while net interest and dividend income was $23.2 million. A preliminary cash-adjusted valuation assigns about $6.0 billion to operations and future projects. Management cited Groves reaching first criticality and updated cash-use guidance.

$OKLOMedAI 8/10

Oklo’s (OKLO) Groves Reactor Hits Criticality In Under A Year

Oklo Inc. (NYSE:OKLO) said its Groves Isotope Test Reactor in Lockhart, Texas, reached first criticality on Aug. 6, less than a year after groundbreaking. The company said it is the first Reactor Pilot Program project to reach criticality on private land from a greenfield site. Oklo reported a quarterly net loss of $81.6M and raised 2026 cash flow and capex guidance.

$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.